Back to Trades
Adams Kendra
Chief Financial OfficerCIK 0001991929
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Adams Kendra, Chief Financial Officer, has disclosed $51.2K in transactions — all concentrated in C4 Therapeutics, Inc. (CCCC). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Sep 21 | CCCC C4 Therapeutics, Inc. | Adams Kendra | Chief Financial Officer | Exercise | $9.4K |
| Feb 18 | CCCC C4 Therapeutics, Inc. | Adams Kendra | Chief Financial Officer | Grant | $32.6K |
| Sep 19 | CCCC C4 Therapeutics, Inc. | Adams Kendra | Chief Financial Officer | Exercise | $9.2K |
3 filings